Article
Use of IgM monoclonal reagents licensed for tube tests in column agglutination technology.
Transfusion - 1 Jan 2000
Morelati F, Burlini A, Reis K J, Drago F, Revelli N, Villa M A, Guffanti A, Italiano Z, Parravicini A, Rebulla P, Sirchia G
Abstract excerpt
BACKGROUND: Red cell (RBC) phenotyping using column agglutination technology (CAT) is currently limited by the reagents formulated in the system. To overcome this limitation, it was investigated whether monoclonal IgM reagents licensed for use with tube tests produced valid results with CAT. STUDY DESIGN AND METHODS: Commercial CAT, does not contain antisera, was used to evaluate Procedures A (40 microL of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
